Ginwa Enterprise Group Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ginwa Enterprise Group Inc. with three other
companies in this sector in CHINA :
Tibet Weixinkang Medicine Co Ltd
sales of 740.96 million Chinese Renmimbi [US$108.54 million]
of which 100%
was Manufacture of Medicines),
Chengdu Huasun Technology Group Co Ltd
(745.34 million Chinese Renmimbi [US$109.18 million]
of which 87%
was Medicine Manufacturing), and
Zhejiang Garden Bio-Chemical High-Tech Co Ltd
(718.38 million Chinese Renmimbi [US$105.23 million]
of which 99%
During the year ended December of 2019, sales at
Ginwa Enterprise Group Inc. were 753.73 million Chinese Renmimbi (US$110.41 million).
a very small
increase of 1.3%
versus 2018, when the company's sales were 744.13 million Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2017, when Ginwa Enterprise Group Inc.
reported sales of 756.60 million Chinese Renmimbi.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Ginwa Enterprise Group Inc. had sales
of 712.79 million Chinese Renmimbi.
Sales of Pharmaceutical Industry saw an increase
that was more than double the company's growth rate: sales were up
8.4% in 2019, from
585.30 million Chinese Renmimbi to 634.71 million Chinese Renmimbi.
Not all segments of Ginwa Enterprise Group Inc. experienced an increase in sales in 2019:
sales of Pharmaceutical Commerce fell 27.9% to 86.96 million Chinese Renmimbi.
Ginwa Enterprise Group Inc. also experienced decreases in sales in
Hotel (down 13.5% to 36.68 million Chinese Renmimbi)